Table 2.

Antitumor efficacy of the different treatment groups in the MBT2 bearing xenograft mouse model.

Treatment Groups	Average Tumor Weight (g)	Tumor Growth Inhibition (%)	IHC Score
			IL-6	CD4
Control	4.31 ± 0.15	-	0	0
CWS-L	3.51 + 0.12	18.56	2	1
CWS-FL	2.83 ± 0.06	34.38	2	2
CWS-PL	2.42 ± 0.06	43.85	3	4
CWS-FPL	2.26 ± 0.05	47.56	4	4

Data represent mean ± standard deviation (SD; n = 4–5).